AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NOXOPHARM LTD

0.064

-0.011-14.67%

Volume:254.22K

Turnover:16.56K

Market Cap:19.66M

PE:-4.27

High:0.071

Open:0.071

Low:0.064

Close:0.075

52wk High:0.110

52wk Low:0.051

Shares:307.24M

Float Shares:195.51M

Volume Ratio:45.65

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.015

EPS(LYR):-0.015

ROE:-343.56%

ROA:-66.95%

PB:-5.39

PE(LYR):-4.27

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment-0.08%

Pharmaceutical Companies-0.27%

Capital Flow

Inflow:

Outflow:

News

Noxopharm Ltd-Sof-Skn to Progress to Extension Study in Cle Patients

THOMSON REUTERS

Noxopharm Ltd-pre-ind Meeting Request with US FDA

THOMSON REUTERS

Noxopharm Ltd-sofr Platform Versatility Shown Via Childbirth Mrff Grant

THOMSON REUTERS

BRIEF-Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/NOX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NOX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","market":"AU","secType":"STK","nameCN":"NOXOPHARM LTD","latestPrice":0.064,"timestamp":1789521843874,"preClose":0.075,"halted":0,"volume":254223,"delay":0,"changeRate":-0.1466666666666666,"nameEN":"NOXOPHARM LTD","floatShares":195506720,"shares":307237950,"eps":-0.015,"marketStatus":"Trading","change":-0.011,"latestTime":"09-16 11:39:24 AEST","open":0.071,"high":0.071,"low":0.064,"amount":16562,"amplitude":0.093333,"askPrice":0.066,"askSize":6134,"bidPrice":0.064,"bidSize":66402,"shortable":3,"etf":0,"ttmEps":-0.015,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.075,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":45.647846,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NOX.AU","preClose":0.073,"auctionPrice":0.075,"auctionVolume":6693,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020000487}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","floatShares":195506720,"roa":"-66.95%","roe":"-343.56%","lyrEps":-0.015,"volumeRatio":45.647846,"shares":307237950,"dividePrice":0,"high":0.071,"amplitude":0.093333,"preClose":0.075,"low":0.064,"week52Low":0.051,"pbRate":"-5.39","psRate":"13.78","week52High":0.11,"institutionHeld":0,"latestPrice":0.064,"committee":0.83087,"eps":-0.015,"divideRate":0,"volume":254223,"delay":0,"ttmEps":-0.015,"open":0.071,"prevYearClose":0.093,"prevWeekClose":0.072,"prevMonthClose":0.089,"prevQuarterClose":0.087,"fiveDayClose":0.073,"twentyDayClose":0.076,"sixtyDayClose":0.092,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NOX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NOX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NOX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667163349","title":"Noxopharm Ltd-Sof-Skn to Progress to Extension Study in Cle Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2667163349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667163349?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:23","pubTimestamp":1789338203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nTUE5TRD03:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","NOX.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649167273","title":"Noxopharm Ltd-pre-ind Meeting Request with US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2649167273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649167273?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:34","pubTimestamp":1783380884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUE9YSG0Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","NOX.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648524672","title":"Noxopharm Ltd-sofr Platform Versatility Shown Via Childbirth Mrff Grant","url":"https://stock-news.laohu8.com/highlight/detail?id=2648524672","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648524672?lang=en_us&edition=fundamental","pubTime":"2026-07-02 06:15","pubTimestamp":1782944152,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nTUE5KVLW6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","NOX.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642845350","title":"BRIEF-Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2642845350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642845350?lang=en_us&edition=fundamental","pubTime":"2026-06-09 09:22","pubTimestamp":1780968176,"startTime":"0","endTime":"0","summary":"BRIEF-Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial ReadinessJune 9 (Reuters) - Noxopharm Ltd NOX.AX:SOF-SKN MANUFACTURING BEGINS TO ENSURE CLINICAL TRIAL READINESS Further company coverage: NOX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42G13S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NOX.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NOX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":-0.00079},{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":-0.002715}]}}